Skip to content

Who is the oldest to survive progeria?

5 min read

As of late 2024, the longest-living individual with classic Hutchinson-Gilford Progeria Syndrome was Italian biologist and activist Sammy Basso, who lived to be 28 years old. While his passing was a great loss to the community, his life significantly advanced research and awareness, challenging previous assumptions about who is the oldest to survive progeria.

Quick Summary

The record for the longest survival with classic progeria is held by Sammy Basso, who died at age 28 in October 2024. Other long-living individuals with progeria have also pushed the boundaries of the disease's typical lifespan. Advancements in treatment and the dedication of patients and researchers have been instrumental in extending lives and improving outcomes.

Key Points

  • Longest Survivor with Classic Progeria: The record is held by Sammy Basso, an Italian biologist and activist, who lived to be 28 years old before passing away in October 2024.

  • Longest-Living Individual with a Progeroid Syndrome: Tiffany Wedekind, a patient with a milder variant of the disease, was reported to be 45 years old in 2023 and is considered one of the longest-living individuals with a progeroid syndrome.

  • Impactful Advocacy: Both Sammy Basso and Tiffany Wedekind have become influential public figures, raising significant awareness and contributing to research efforts.

  • Increased Life Expectancy: Recent medical advancements, including the drug lonafarnib, have increased the average lifespan for patients from 14.5 to nearly 20 years.

  • Progeroid Syndrome Variations: The existence of long-term survivors like Wedekind highlights that there can be variations in the severity and progression of progeroid syndromes.

  • Average Lifespan: Despite record-breaking survival stories, the average life expectancy for a child with classic progeria remains in the teens, with death typically caused by cardiovascular complications.

In This Article

Understanding the longest-living progeria patients

For many years, the life expectancy for those with Hutchinson-Gilford Progeria Syndrome (HGPS), or progeria, was believed to be limited to the early teens, with an average lifespan of around 14.5 years. However, the resilience and contributions of specific individuals have redefined what is possible. These individuals, through their participation in research and advocacy, have helped increase the average lifespan and offer hope to others with the condition.

Sammy Basso: Classic Progeria record holder

Until his death in October 2024, Italian biologist and activist Sammy Basso was recognized as the longest-living survivor of classic progeria. He passed away at the age of 28, well beyond the typical life expectancy. Basso's life was a testament to his vibrant spirit and intellectual curiosity. He earned two university degrees and became a dedicated ambassador for the Progeria Research Foundation (PRF). His work and participation in clinical trials were crucial in advancing the scientific community's understanding of the disease. Basso famously documented his life in the Italian National Geographic series, "Il Viaggio Di Sammy," sharing his journey with a global audience and raising significant awareness.

Tiffany Wedekind: A different variant and diagnosis

Another well-known long-term survivor is Tiffany Wedekind of Columbus, Ohio. Unlike many cases, her progeria went undiagnosed until her twenties, and she represents a different variant of the disease, which may explain her longer lifespan. In August 2023, she was reported to be 45 years old, making her one of the longest-living individuals with a progeroid syndrome. Wedekind, an artist and yoga enthusiast, demonstrates incredible resilience despite facing significant health challenges caused by accelerated aging. Her story, though different from classic HGPS, provides further insight into the complexities of the progeria spectrum.

Leon Botha: An early milestone

Before Basso's record, Leon Botha, a South African artist and DJ, was considered one of the longest-living individuals with progeria. Botha was diagnosed at age four and lived until he was 26, passing away in 2011. His life was marked by artistic expression and a profound impact on those around him. Like Basso, Botha's story brought much-needed attention to the condition and showcased a person with progeria living a full, creative life. His existence pushed the boundaries of what many thought was possible, paving the way for greater optimism and research.

Advancements in progeria treatment

The extended lifespans observed in individuals like Basso and Wedekind are not just due to chance. Major strides have been made in managing the symptoms of progeria, largely due to focused research and clinical trials.

  • Lonafarnib: The first approved treatment for HGPS was lonafarnib, a farnesyltransferase inhibitor. Clinical trials showed that this drug could increase the average life expectancy of children with progeria by several years. It works by targeting the abnormal protein, progerin, which is responsible for the rapid aging symptoms.
  • Gene Editing and Molecular Biology: Sammy Basso himself contributed to research in this area, pursuing a degree in Molecular Biology. Gene editing techniques offer new avenues for treatment by directly correcting the genetic mutation that causes progeria, though this is still in the research phase.
  • Supportive Care: In addition to targeted drug treatments, comprehensive supportive care has improved quality of life. This includes managing cardiovascular issues, providing nutritional support, and physical therapy to address joint stiffness.

Comparison of notable long-term survivors

Feature Sammy Basso Tiffany Wedekind Leon Botha
Lifespan 28 years (1995-2024) 45 years (as of 2023) 26 years (1985-2011)
Progeria Type Classic Hutchinson-Gilford Progeria Syndrome Likely a different, milder progeroid variant Classic Hutchinson-Gilford Progeria Syndrome
Primary Contributions Activism, research, university education Artist, yoga instructor, advocacy Painter, DJ, artistic collaboration
Diagnosis Early childhood Adulthood Early childhood

Challenges and continued research

Despite remarkable stories of longevity, progeria remains a fatal condition with no definitive cure. The extended lifespans of individuals like Basso and Wedekind are exceptions rather than the rule. Research efforts continue to focus on understanding the underlying mechanisms of the disease and developing more effective treatments. The Progeria Research Foundation, founded by the parents of another well-known patient, Sam Berns, plays a vital role in these efforts.

Conclusion

The question of who is the oldest to survive progeria reveals a narrative of inspiring resilience and ongoing scientific progress. While Sammy Basso holds the recent record for the longest survival with classic progeria, others like Tiffany Wedekind have also defied expectations. These individuals not only lived longer but also made invaluable contributions to research and public awareness. Their legacies motivate scientists and caregivers to continue the search for more effective therapies and, one day, a cure for this rare and challenging genetic disorder. The progress seen in extending the average lifespan from 14.5 to nearly 20 years is a testament to the power of dedicated research and clinical trials, offering renewed hope for the future.

Ongoing research and public awareness

The stories of long-term survivors have helped drive public awareness and funding for critical research. Organizations like the Progeria Research Foundation have become central hubs for families and scientists, coordinating clinical trials and supporting affected individuals. The media spotlight on remarkable individuals has transformed a little-known disease into a cause with global recognition, driving the search for a cure further than ever before.

The Progeria Research Foundation is a leading non-profit organization dedicated to finding treatments and a cure for Hutchinson-Gilford Progeria Syndrome.

How Progeria impacts the body

The genetic mutation in the LMNA gene leads to the production of an abnormal protein called progerin. This toxic protein destabilizes the cell's nucleus, leading to the rapid aging symptoms associated with progeria. This instability primarily affects the cardiovascular system, which is why heart attacks and strokes are the most common causes of death. Other effects include hair loss, stiff joints, and loss of body fat. While intellect and social development are not typically affected, the physical toll of the disease is immense, making the stories of long-term survivors even more extraordinary.

Living with Progeria

For those living with progeria, life is a constant balance between managing physical limitations and embracing opportunities. Sammy Basso's pursuit of higher education and activism demonstrates the intellectual and spiritual vibrancy that can flourish despite the physical constraints of the disease. Similarly, Tiffany Wedekind's artistic endeavors and yoga practice show a commitment to a rich inner life. These stories challenge the public to see beyond the physical symptoms of the disease and recognize the full humanity of those affected. The fight for a longer, healthier life for future generations of progeria patients is powered by the examples of these courageous individuals who lived each day to the fullest.

Frequently Asked Questions

The average life expectancy for a child with classic Hutchinson-Gilford Progeria Syndrome is typically around 14.5 years, though some individuals have lived into their early 20s or longer. With treatment, the average life expectancy has increased to almost 20 years.

Sammy Basso was an Italian biologist and activist who was known as the longest-living person with classic progeria. He passed away in October 2024 at the age of 28. His life contributed significantly to progeria research and advocacy.

No, there is currently no cure for progeria. However, treatments like the drug lonafarnib and advancements in supportive medical care have been shown to help manage symptoms and extend life expectancy.

Heart problems and strokes caused by the rapid hardening of the arteries (atherosclerosis) are the most common causes of death in individuals with progeria.

Tiffany Wedekind is an Ohio-based artist and yoga instructor who is considered one of the longest-living people with a progeroid syndrome. She was reported to be 45 years old in 2023 and has a milder variant of the condition that was not diagnosed until adulthood.

Progeria is an extremely rare genetic disorder, affecting approximately 1 in 18 million people worldwide. It is not typically inherited from parents but is caused by a spontaneous genetic mutation.

The approval of the drug lonafarnib and participation in clinical trials have been shown to slow the progression of the disease and increase life expectancy. Combined with improved supportive care, this has allowed many to live longer, more fulfilling lives.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice. Always consult a qualified healthcare provider regarding personal health decisions.